Articles

Radley’s taps Syrris for U.S. Lara sales

Just 18 months after the introduction of its Lara Controlled Laboratory Reactor (CLR) system in the European market, U.K.-based laboratory equipment supplier Radleys announced an exclusive North American distribution partnership for the product with Syrris Inc. The deal covers sales and support of Lara, as well as the Coflux Calorimetry module.
Written byChris Anderson
| 2 min read

RIDGEWOOD, N.J.—Just 18 months after the introduction of its Lara Controlled Laboratory Reactor (CLR) system in the European market, U.K.-based laboratory equipment supplier Radleys announced an exclusive North American distribution partnership for the product with Syrris Inc. The deal covers sales and support of Lara, as well as the Coflux Calorimetry module.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.